Acrivon Therapeutics, Inc. (ACRV)

NASDAQ: ACRV · IEX Real-Time Price · USD

8.86

+0.49 (5.85%)

At close: Jul 26, 2024, 4:00 PM

8.93

+0.07 (0.79%)

After-hours: Jul 26, 2024, 6:36 PM EDT

Acrivon Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-64.12	-60.39	-31.17	-16.24	-5.31
Depreciation & Amortization	0.64	0.54	0.36	0.04	0.01
Loss (Gain) From Sale of Investments	-2.77	-3.32	-0.7	-	-
Stock-Based Compensation	12.32	11.62	2.19	0.5	0
Other Operating Activities	0.81	0.78	0.73	1.4	2.17
Change in Accounts Payable	0.87	3.61	-0.25	0.8	0.08
Change in Other Net Operating Assets	3.89	4.53	-1.29	-0.47	0.24
Operating Cash Flow	-48.37	-42.64	-30.12	-13.98	-2.8
Capital Expenditures	-2.08	-1.29	-2.17	-0.24	-0.02
Investment in Securities	49.32	52.01	-139.51	-	-
Investing Cash Flow	47.24	50.72	-141.68	-0.24	-0.02
Long-Term Debt Issued	-	-	-	-	0.06
Net Debt Issued (Repaid)	-	-	-	-	0.06
Issuance of Common Stock	0.85	0.78	104.48	0	-
Repurchase of Common Stock	-1.46	-1.3	-	-	-
Other Financing Activities	-1.12	-1.03	-2.77	-	-
Financing Cash Flow	-1.73	-1.55	101.71	112.22	2.89
Net Cash Flow	-2.85	6.52	-70.08	98	0.07
Free Cash Flow	-50.45	-43.93	-32.28	-14.22	-2.82
Free Cash Flow Per Share	-2.27	-1.99	-7.83	-8.16	-1.97
Levered Free Cash Flow	-28.6	-22.33	-20.03	-8.79	-
Unlevered Free Cash Flow	-28.38	-22.33	-20.03	-8.79	-
Change in Net Working Capital	-4.74	-8.75	-0	-1.03	-

Source: S&P Capital IQ. Standard template.